Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance

World News: . []

NEW HAVEN Conn Feb 15 2018 GLOBE NEWSWIRE -- Precipio Inc NASDAQPRPO LINK  today its launch of the first lung cancer LINK  resistance panel specifically for the critical mutations T790M and C797S in the EGFR gene The test will use Pr...

More news and information about Precipio, Inc.

Published By:

Globe Newswire: 13:38 GMT Thursday 15th February 2018

Published: .

Search for other references to "precipio" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us